Glycosylation stability

This ester was designed as a protective group for the 2-position in glycosyl donors. It has the stability of the benzoate during glycosylation, but has the ease of removal of the chloroacetate. It is readily introduced through the acid chloride... 

Heparin sulfate proteoglycans (HSPGs) are heavily glycosylated proteins that are part of the extracellular matrix. Interaction with HSPGs help to stabilize and localize extracellular Wnts. 

An Sn 1 -like reaction, on the other hand, is much more favorable, because the glycosyl cation intermediate is stabilized by charge distribution between C-1 and the ring-oxygen atom. The unfavorable formation of an ion pair on bond cleavage can be avoided by protonation of the glycosidic oxygen atom and thus the requirement for acid catalysis (see Scheme 1). 

Stabilities and colors of anthocyanins are dependent on the nature and number of sugars attached to the flavylium ion and the nature and number of acids linked to the glycosylic moiety. Tint and hue, however, are related to the numbers and positions of hydroxyl and methoxyl substituents in the flavylium ion. In addition, 3-deoxy-anthocyanins that are yellow due to dehydroxylation of the carbon at C-3 have higher stabilities than the corresponding 3-hydroxy anthocyanins that in turn are red but lose much of their stability. 

The pKj, value (2.43) of the hydration constant of the cyanidin was found to be lower than the pKj, values of glycosylated and acylated cyanidins, meaning lower resistance of the anthocyanidin to hydration. The stability of nonacylated 3,5-diglucosides was lower compared to the 3-glucoside because the 5 position markedly lowered the hydration constant due to decreased electron density of the pyrilium ring that favors nucleophilic attack by water, enhancing hemiacetal formation. ... 

The psubunit has been purified from PGl by ourselves and others and is a heat stable, acidic, heavily glycosylated protein with an apparent molecular mass of 37-39 kD (19, 26). No enzymatic activity has been identified for the protein. The psubunit can be extracted from the cell walls of both green and ripe tomato fruit by high salt buffers (13, 14, 18, 19, 20), and in the latter case is associated with PG2 polypeptide(s) in the form of PGl. Purified psubunit can also associate with and convert PG2 in vitro into an isoenzyme that closely resembles PGl (13, 14, 24). Biochemical studies have shown that in vivo and in vitro formation of PGl by the association of PG2 with the p-subunit alters the biochemical and enzymic properties of the associated catalytic PG2 polypeptide including its pH optima, response to cations and thermal stability (summarized in Table 1). This later property provides a convenient assay for the levels of PGl and PG2 in total cell wall protein extracts. 

Park, M. and Tenner, A.J. (2003) Cell surface expression of ClqRP/CD93 is stabilized by O-glycosylation. Journal of Cellular Physiology, 196 (3), 512—522. 

Glycosylation affects protein stability as well as immunogenicity. A prominent example is tobacco-derived erythropoeitin (EPO), which possesses smaller N-linked oligo-... 

For other plant-derived antibodies, stability was shown to be similar to mammalian counterparts. For instance, a humanized anti-herpes simplex virus monoclonal antibody (IgGl) was expressed in soybean and showed stability in human semen and cervical mucus over 24 h similar to the antibody obtained from mammalian cell culture. In addition, the plant-derived and mammalian antibodies were tested in a standard neutralization assay with no apparent differences in their ability to neutralize HSV-2. As glycans may play a role in immune exclusion mechanisms in mucus, the diffusion of these monoclonal antibodies in human cerival mucus was tested. No differences were found in terms of the prevention of vaginal HSV-2 transmission in a mouse model, i.e. the plant-derived antibody provided efficient protection against a vaginal inoculum of HSV-2 [58]. This shows that glycosylation differences do not necessarily affect efficacy. 

Many polypeptides undergo covalent modification after (or sometimes during) their ribosomal assembly. The most commonly observed such PTMs are listed in Table 2.7. Such modifications generally influence either the biological activity or the structural stability of the polypeptide. The majority of therapeutic proteins bear some form of PTM. Although glycosylation represents the most common such modification, additional PTMs important in a biopharmaceutical context include carboxylation, hydroxylation, sulfation and amidation these PTMs are now considered further. 

---